|
1.
|
Alvarez S, Suela J, Valencia A, et al: DNA
methylation profiles and their relationship with cytogenetic status
in adult acute myeloid leukemia. PLoS One. 5:e121972010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Roman-Gomez J, Jimenez-Velasco A, Agirre
X, et al: Promoter hypermethylation and global hypomethylation are
independent epigenetic events in lymphoid leukemogenesis with
opposing effects on clinical outcome. Leukemia. 20:1445–1447. 2006.
View Article : Google Scholar
|
|
3.
|
Kraszewska MD, Dawidowska M, Larmonie NSD,
et al: DNA methylation pattern is altered in childhood T-cell acute
lymphoblastic leukemia patients as compared with normal thymic
subsets: insights into CpG island methylator phenotype in T-ALL.
Leukemia. 26:367–371. 2011. View Article : Google Scholar
|
|
4.
|
Holz-Schietinger C, Matje DM, Harrison MF
and Reich NO: Oligomerization of DNMT3A controls the mechanism of
de novo DNA methylation. J Biol Chem. 286:41479–41488. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ley TJ, Ding L, Walter MJ, et al: DNMT3A
mutations in acute myeloid leukemia. N Engl J Med. 363:2424–2433.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Li X, Cen J, Wang Q, et al: Absence of
DNMT3A gene mutation in chronic myeloid leukemia patients in blast
crisis. Eur J Haematol. 88:455–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Shen Y, Zhu YM, Fan X, et al: Gene
mutation patterns and their prognostic impact in a cohort of 1185
patients with acute myeloid leukemia. Blood. 118:5593–5603. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jankowska AM, Makishima H, Tiu RV, et al:
Mutational spectrum analysis of chronic myelomonocytic leukemia
includes genes associated with epigenetic regulation: UTX, EZH2 and
DNMT3A. Blood. 118:3932–3941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Walter MJ, Ding L, Shen D, et al:
Recurrent DNMT3A mutations in patients with myelodysplastic
syndromes. Leukemia. 25:1153–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Couronné L, Bastard C and Bernard OA: TET2
and DNMT3A mutations in human T-Cell lymphoma. N Engl J Med.
366:95–96. 2012.PubMed/NCBI
|
|
11.
|
Stegelmann F, Bullinger L, Schlenk RF, et
al: DNMT3A mutations in myeloproliferative neoplasms. Leukemia.
25:1217–1219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bennett JM, Catovsky D, Daniel MT, et al:
Proposals for the classification of the acute leukaemias.
French-American-British (FAB) co-operative group. Br J Haematol.
33:451–458. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Qiao SK, Xu SR, Guo XN and Wang Y:
Clinical significance of the expression of DNA methyltransferase
genes (DNMT) in acute leukemia patients. Zhongguo Shi Yan Xue Ye
Xue Za Zhi. 13:260–265. 2005.(In Chinese).
|
|
14.
|
Challen GA, Sun D, Jeong M, et al: Dnmt3a
is essential for hematopoietic stem cell differentiation. Nat
Genet. 44:23–31. 2011. View
Article : Google Scholar
|
|
15.
|
Cheson BD, Bennett JM, Kopecky KJ, et al:
Revised recommendations of the International Working Group for
diagnosis, standardization of response criteria, treatment
outcomes, and reporting standards for therapeutic trials in acute
myeloid leukemia. J Clin Oncol. 21:4642–4649. 2003. View Article : Google Scholar
|
|
16.
|
Ribeiro AF, Pratcorona M,
Erpelinck-Verschueren C, et al: Mutant DNMT3A: a marker of poor
prognosis in acute myeloid leukemia. Blood. 119:5824–5831. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yan XJ, Xu J, Gu ZH, et al: Exome
sequencing identifies somatic mutations of DNA methyltransferase
gene DNMT3A in acute monocytic leukemia. Nat Genet. 43:309–315.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kim MS, Kim YR, Yoo NJ and Lee SH:
Mutational analysis of DNMT3A gene in acute leukemias and common
solid cancers. APMIS. 121:85–94. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Yamashita Y, Yuan J, Suetake I, et al:
Array-based genomic resequencing of human leukemia. Oncogene.
29:3723–3731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Shen L, Kantarjian H, Guo Y, et al: DNA
methylation predicts survival and response to therapy in patients
with myelodysplastic syndromes. J Clin Oncol. 28:605–613. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Figueroa ME, Lugthart S, Li Y, et al: DNA
methylation signatures identify biologically distinct subtypes in
acute myeloid leukemia. Cancer Cell. 17:13–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ho PA, Kutny MA, Alonzo TA, et al:
Leukemic mutations in the methylation-associated genes DNMT3A and
IDH2 are rare events in pediatric AML: a report from the Children’s
Oncology Group. Pediatr Blood Cancer. 57:204–209. 2011.PubMed/NCBI
|
|
23.
|
Hollink IH, Feng Q, Danen-van Oorschot AA,
et al: Low frequency of DNMT3A mutations in pediatric AML and the
identification of the OCI-AML3 cell line as an in vitro model.
Leukemia. 26:371–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hollink IH, Zwaan CM, Zimmermann M, et al:
Favorable prognostic impact of NPM1 gene mutations in childhood
acute myeloid leukemia, with emphasis on cytogenetically normal
AML. Leukemia. 23:262–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
